Results 111 to 120 of about 3,339 (149)

Comparison of Intraoperative Blood Loss in Monopolar Transurethral Resection of the Prostate With and Without Two Weeks of Preoperative Dutasteride. [PDF]

Cureus
Shaukat Ali A, Anwar M, Abrar M, Azeem MF, Bilal M, Ali W, Idrees MR, Ashraf F.   +7 more
europepmc   +1 more source

Enhanced hair regrowth with five monthly sessions of minoxidil-dutasteride-copper peptides tattooing for androgenetic alopecia assessed by artificial intelligence and blinded evaluators. [PDF]

JAAD Int
Kuceki G, Coppinger AJ, Ragi SD, Johnson LS, Goren A, Kalil LL, Cirino P, Wambier CG.   +7 more
europepmc   +1 more source

Paradoxical Nonscarring Alopecia Following Mesotherapy with Dutasteride: A Case Series.

Int J Trichology
Chandrashekhar M, Chandrashekar BS, Madura C, Shenoy C.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Dutasteride

Drugs & Aging, 2003
Dutasteride, a potent inhibitor of type 1 and 2 5alpha-reductase, reduced dihydrotestosterone levels by >90% in 85% of patients following 1 years' administration of oral dutasteride 0.5 mg/day. A combined analysis of three placebo-controlled clinical studies conducted in patients with benign prostatic hyperplasia (BPH) found sustained improvements in ...
Hannah C, Evans, Karen L, Goa
  +7 more sources

The Cardiovascular Safety of Dutasteride

Journal of Urology, 2017
Randomized controlled trials suggest an increased risk of heart failure with dutasteride, which inhibits both the type 1 and type 2 isoforms of 5α-reductase. In contrast, no such association has been suggested for finasteride, which selectively inhibits the type 2 isoform.
Sean C, Skeldon, Erin M, Macdonald, Michael R, Law, Anjie, Huang, J Michael, Paterson, Muhammad M, Mamdani, David, Juurlink   +6 more
openaire   +2 more sources

Dutasteride/Tamsulosin

Drugs & Aging, 2012
The 5α-reductase inhibitor dutasteride and the α(1)-adrenergic receptor antagonist tamsulosin are available as a fixed-dose combination for use in men with symptomatic benign prostatic hyperplasia (BPH) and an enlarged prostate. Dutasteride 0.5 mg/day plus tamsulosin 0.4 mg/day improved lower urinary tract symptoms (LUTS) to a significantly greater ...
openaire   +2 more sources

Dutasteride

Reactions Weekly, 2021
openaire   +2 more sources

Dutasteride and Prostate Cancer Risk

Current Urology Reports, 2010
In a previously published and heavily discussed paper [1], the type 2 5-α-reductase inhibitor (5ARI) finasteride was shown to reduce the risk of prostate cancer by a substantial 25% as compared to placebo in men at no known risk of developing prostate cancer.
openaire   +2 more sources